Description
Using real-world data, the goals of this project are to understand the impacts of COVID-19 on (1) cancer care management, including detection, diagnosis and treatment of cancer, (2) patient-reported experience, and (3) costs of cancer care.
Specific Aims are:
Aim 1: Examine how cancer care is delivered in the ongoing COVID period. We will examine the patterns of care (telemedicine use and care disruption/recovery) over time following California’s shelter-in-place order and the subphases in the ongoing COVID period, and by patient characteristics (age, sex, race/ethnicity, language, cancer type, comorbidity, socioeconomic status).
Aim 2: Understand the impact of COVID-19 on patient experiences with and preferences for care. We will compare patient experience with care across patient groups: (a) between pre-COVID and ongoing COVID periods, and (b) between in-person visits and telemedicine visits.
Aim 3: Assess the economic impacts of COVID-19 in cancer care management. We will examine whether the distribution of cancer stage at diagnosis is shifted in the ongoing COVID period, with potential delay in care. We will compare subsequent costs of care between the two periods.
With Monique de Bruin, M.D., MPH, as physician lead, John K. Chan, M.D., Natalia Colocci, M.D., Ph.D., and Allison W. Kurian M.D., MSc, serve as physician advisors.
Principal Investigator
Co-Investigator(s)
Monique de Bruin, M.D., MPH, Cheryl Stults, Ph.D.
Funder
UC Office of the President, Research Grants Program Office
Research Topics
Related Studies
Cancer Liquid Biopsy Monitoring Study
Investigators: Mohammed Kashani-Sabet, M.D., Deepti Behl, MD
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigator: Su-Ying Liang, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigator: Jiang Li, Ph.D., MPH
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator